Date published: 2026-4-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

cathepsin V Inhibitors

Cathepsin V (CTSV) inhibitors encompass a range of chemical compounds designed to selectively target and inhibit the proteolytic activity of Cathepsin V, a lysosomal cysteine protease. These inhibitors are primarily characterized by their binding affinity and mechanism of action against the active site of CTSV, a crucial aspect in their inhibitory function. The inhibitors listed, such as E-64, Z-FA-FMK, and K11777, demonstrate diverse chemical structures and modes of inhibition, ranging from irreversible covalent binding to reversible interactions. The chemical nature of these inhibitors enables them to interact specifically with the cysteine residue at the active site of CTSV, thereby blocking its proteolytic activity. This interaction is vital for the inhibition process, as it prevents the protease from cleaving its peptide substrates. The inhibitors vary in their specificity and potency. For example, E-64 and its derivatives are known for their strong irreversible inhibition, forming a covalent bond with the active site cysteine. In contrast, compounds like Leupeptin Hemisulfate exhibit reversible inhibition, offering a different approach to modulating CTSV activity. The versatility in inhibition modes provides a broad spectrum of tools for studying and potentially regulating CTSV's role in various biological processes. Fluoromethylketone-based inhibitors, such as Z-FA-FMK, and chloromethyl ketone derivatives, like N-Peptidyl-O-Phenylalanine Chloromethyl Ketone, showcase the chemical
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Z-FA-FMK

197855-65-5sc-201303
sc-201303A
1 mg
5 mg
$128.00
$372.00
19
(1)

Z-FA-FMK is a fluoromethylketone-based inhibitor that forms a covalent bond with the active site of CTSV, rendering it inactive.

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$153.00
$356.00
15
(1)

K11777 is a potent, irreversible peptidyl inhibitor, targeting the active site of CTSV and preventing its protease function.

CA-074

134448-10-5sc-202513
1 mg
$321.00
(0)

CA-074 is a selective, irreversible inhibitor of CTSV, specifically targeting and modifying its active site cysteine residue.

MDL-28170

88191-84-8sc-201301
sc-201301A
sc-201301B
sc-201301C
10 mg
50 mg
100 mg
500 mg
$69.00
$241.00
$447.00
$2195.00
20
(2)

MDL-28170 is a broad-spectrum cysteine protease inhibitor, with a particular affinity for inhibiting CTSV through active site interaction.

VX-765

273404-37-8sc-475845
sc-475845A
sc-475845B
5 mg
10 mg
50 mg
$228.00
$302.00
$968.00
1
(0)

VX-765, also known as Belnacasan, is a prodrug that is metabolized into a potent inhibitor of CTSV, effectively blocking its protease activity.

Leupeptin hemisulfate

103476-89-7sc-295358
sc-295358A
sc-295358D
sc-295358E
sc-295358B
sc-295358C
5 mg
25 mg
50 mg
100 mg
500 mg
10 mg
$73.00
$148.00
$316.00
$499.00
$1427.00
$101.00
19
(3)

Leupeptin Hemisulfate is a reversible inhibitor that binds to the active site of CTSV, thereby inhibiting its proteolytic function.

SID 26681509

958772-66-2sc-361358
sc-361358A
10 mg
50 mg
$421.00
$1569.00
1
(0)

SID 26681509 acts as a competitive inhibitor of CTSV, binding to its active site and preventing substrate access.

Odanacatib

603139-19-1sc-364675
sc-364675A
sc-364675B
5 mg
25 mg
250 mg
$218.00
$993.00
$1982.00
2
(1)

Odanacatib selectively inhibits CTSV by binding to its active site, thereby reducing its protease activity without affecting other cathepsins.

Tris(dibenzylideneacetone)dipalladium(0)

51364-51-3sc-253790
sc-253790A
sc-253790B
sc-253790C
500 mg
1 g
10 g
50 g
$56.00
$107.00
$629.00
$3124.00
(0)

This chloromethyl ketone derivative acts as an irreversible inhibitor of CTSV by modifying its active site cysteine residue.